Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Howard

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
European Journal of Haematology|August 17, 2019
Impact of central nervous system involvement in AML on outcomes after allotransplant and utility of pretransplant cerebrospinal fluid assessmentShruti Prem, Eshetu G Atenafu, Jose Avena, et al.
European Journal of Haematology|January 31, 2022
Allogeneic hematopoietic stem cell transplantation in patients with therapy-related hematologic malignancies developing after multiple myelomaRam Vasudevan Nampoothiri, Ivan Pasic, Arjun Datt Law, et al.
European Journal of Haematology|March 30, 2019
Low rates of acute and chronic GVHD with ATG and PTCy in matched and mismatched unrelated donor peripheral blood stem cell transplantsShruti Prem, Eshetu G Atenafu, Zeyad Al-Shaibani, et al.
European Urology Oncology|April 2, 2023
Perioperative Complications and Oncologic Outcomes of Nephrectomy Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative StudyWesley Yip, Alireza Ghoreifi, Thomas Gerald, et al.
European Journal of Haematology|March 3, 2020
Outcomes of therapy-related acute lymphoblastic leukemia in adults after allogeneic stem cell transplantationRam Vasudevan Nampoothiri, Arjun Datt Law, Wilson Lam, et al.
Hematology/Oncology and Stem Cell Therapy|March 29, 2021
Predictors of Outcomes of Therapy-Related Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell TransplantationRam Vasudevan Nampoothiri, Arjun Datt Law, Wilson Lam, et al.
Clinical Hematology International|October 1, 2021
Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-transplantation Cyclophosphamide and Anti-thymocyte Globulin as Graft-<i>versus</i>-Host Disease ProphylaxisMaria Queralt Salas, Arjun Datt Law, Wilson Lam, et al.
Cureus|April 2, 2024
Advancing Treatment in Atopic Dermatitis: A Comprehensive Review of Clinical Efficacy, Safety, and Comparative Insights Into Corticosteroids, Calcineurin Inhibitors, and Phosphodiesterase-4 Inhibitors as Topical TherapiesTyler D Hernandez, Sarah J Aleman, Maria Bao-Loc-Trung, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 16, 2022
Relationship between certain HLA alleles and the risk of cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantationShruti Prem, Mats Remberger, Ahmad Alotaibi, et al.
Cureus|September 2, 2024
Pathophysiology and Evolving Treatment Options of Septic Arthritis: A Narrative ReviewAlan D Kaye, Driskell Greene, Alana V Alvarez-Amado, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
European Journal of Haematology|August 17, 2019
Impact of central nervous system involvement in AML on outcomes after allotransplant and utility of pretransplant cerebrospinal fluid assessmentShruti Prem, Eshetu G Atenafu, Jose Avena, et al.
European Journal of Haematology|January 31, 2022
Allogeneic hematopoietic stem cell transplantation in patients with therapy-related hematologic malignancies developing after multiple myelomaRam Vasudevan Nampoothiri, Ivan Pasic, Arjun Datt Law, et al.
European Journal of Haematology|March 30, 2019
Low rates of acute and chronic GVHD with ATG and PTCy in matched and mismatched unrelated donor peripheral blood stem cell transplantsShruti Prem, Eshetu G Atenafu, Zeyad Al-Shaibani, et al.
European Urology Oncology|April 2, 2023
Perioperative Complications and Oncologic Outcomes of Nephrectomy Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative StudyWesley Yip, Alireza Ghoreifi, Thomas Gerald, et al.
European Journal of Haematology|March 3, 2020
Outcomes of therapy-related acute lymphoblastic leukemia in adults after allogeneic stem cell transplantationRam Vasudevan Nampoothiri, Arjun Datt Law, Wilson Lam, et al.
Hematology/Oncology and Stem Cell Therapy|March 29, 2021
Predictors of Outcomes of Therapy-Related Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell TransplantationRam Vasudevan Nampoothiri, Arjun Datt Law, Wilson Lam, et al.
Clinical Hematology International|October 1, 2021
Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-transplantation Cyclophosphamide and Anti-thymocyte Globulin as Graft-<i>versus</i>-Host Disease ProphylaxisMaria Queralt Salas, Arjun Datt Law, Wilson Lam, et al.
Cureus|April 2, 2024
Advancing Treatment in Atopic Dermatitis: A Comprehensive Review of Clinical Efficacy, Safety, and Comparative Insights Into Corticosteroids, Calcineurin Inhibitors, and Phosphodiesterase-4 Inhibitors as Topical TherapiesTyler D Hernandez, Sarah J Aleman, Maria Bao-Loc-Trung, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 16, 2022
Relationship between certain HLA alleles and the risk of cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantationShruti Prem, Mats Remberger, Ahmad Alotaibi, et al.
Cureus|September 2, 2024
Pathophysiology and Evolving Treatment Options of Septic Arthritis: A Narrative ReviewAlan D Kaye, Driskell Greene, Alana V Alvarez-Amado, et al.
Pageof 7